INTRODUCTION
Male breast carcinoma is an uncommon neoplasm, accounting for 0.6% of all breast carcinomas and <0.5% of malignancies in men. 1, 2 Mucinous carcinoma, also referred to as colloid carcinoma or gelatinous carcinoma, is histopathologically characterized by the presence of clusters of neoplastic cell is suspended in extensive extracellular mucin, and accounts for ~2% of female breast carcinomas. 3 However, its occurrence in the male breast is extremely rare. 2, 4, 5 Pure mucinous carcinoma is associated with low rates of recurrence and excellent survival rates. In the present study, we report a case of pure mucinous carcinoma occurring in a male breast and review the clinicopathological features of this extremely rare tumor.
CASE REPORT
A 54-year-old male presented with a subareolar firm to hard mass in the left breast, fixed to the overlying skin for 6 months duration. Physical examination revealed a wellcircumscribed nodule, measuring 4x3 cm in diameter, in the left breast. Axillary lymph nodes were not palpable. The provisional diagnosis of carcinoma of breast was made and Fine-Needle Aspiration Cytology (FNAC) was advised. Smears showed abundant mucinous stroma in background with atypical cells lying in groups and also individually dispersed showing round to oval nuclei with regular nuclear margins and 1-2 prominent nucleoli ( Figure 3 ). Modified Radical Mastectomy of left breast was done with ipsilateral axillary dissection ( Figure 2 ).
Grossly the mastectomy specimen was measuring 7x4x4 cm, nipple and areola was normal. Cut section showed a well circumscribed tumour measuring 4x3x3 cm having gelatinous appearance (Figure 2 ). Histopathology showed tumor cells arranged in nests and solid pattern floating in abundant extracellular mucin and thus confirmed the diagnosis of mucinous breast carcinoma ( Figure 3) . The cell clusters are variable in size and shape sometimes with a tubular arrangement rarely, they assume a papillary configuration. 
DISCUSSION
Male Breast Carcinoma (MBC) is an uncommon neoplasm, accounting for 0.6% of all breast carcinomas and <1% of malignancies in men.
1,2 Men present at an older age than women (median age of 64.5 years) and MBC incidence increases with an advancing age. Pure mucinous carcinoma of the male breast is an extremely rare neoplasm. 6 Carcinoma in male breast is hundred times less frequent than in female breast. Radiation exposure, genetic predisposition, chronic liver diseases, and schistosomiasis have been linked to increased incidence of carcinoma in male breast. An association with Klinfelter's syndrome has been noted with 20 times higher frequency. [3] [4] [5] Very few cases of primary mucinous carcinoma have been reported in male breast. 3 The pure form is defined as a lesion with a mucinous carcinoma component in more than 90% of the tumor, and the mixed type has both mucinous and conventional invasive carcinoma components. 3 reported that the prognosis of pure mucinous carcinoma is more favorable than that of mixed type in females. Therefore, certain researchers have suggested that axillary lymph node dissection may be unnecessary for pure mucinous carcinoma, and they recommend sentinel lymph node dissection instead for patients with this form of tumor. 7 However, certain cases of pure mucinous carcinoma with axillary lymph node metastasis in the male breast have been reported. 5, 9, 10 Fine Needle Aspiration Cytology (FNAC) is an easy and useful procedure for the diagnosis of breast tumors. A few cases of mucinous carcinoma of the male breast successfully diagnosed by FNAC have been reported. 9 In our case mucinous carcinoma has been diagnosed primarily on FNAC. Prognosis in male breast carcinoma is poor, maybe due to the smaller size of breast mass, which increases the probability of the involvement of surrounding structures. Prognosis depends on the stage at diagnosis as determined by tumor size and nodal metastasis. 4 Estrogen receptor and progesterone receptor positivity has been noted in 90% of cases. 5, 6 Pure mucinous carcinoma is associated with a better prognosis and a low rate for axillary lymph node metastases.
